Illumina, Inc. (ILMN) CEO Francis deSouza on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/28/21
Illumina, Kartos Therapeutics Team Up To Develop Companion Diagnostic For TP53-Haboring Cancer IndicationsBenzinga • 04/23/21
Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion DiagnosticBusiness Wire • 04/22/21
Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood TestBusiness Wire • 04/20/21
Illumina Stock Pops As Covid Surveillance Helps Drive Unexpected Beat And RaiseInvestors Business Daily • 04/06/21
Illumina stock rallies 13% after biotech says it expects Q1 sales to top $1 billionMarket Watch • 04/05/21